|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||
|
||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s2529760E-3B5B-11EF-9F4D-F83685CE164B&I=39IZM&T=&OP=Display&O=html&O1=12884968&O2=1000000000428820&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DAssessing%2520the%2520potential%2520impact%2520of%2520non-proprietary%2520drug%2520copies%2520on%2520quality%2520of%2520medicine%2520and%2520treatment%2520in%2520patients%2520with%2520relapsing%2520multiple%2520sclerosis%253A%2520the%2520experience%2520with%2520fingolimod%26rft.au%3DChiquete%252C%2520Erwin%26rft.au%3DCorreale%252C%2520Jorge%26rft.au%3DFrider%252C%2520Nadina%26rft.au%3DMilojevic%252C%2520Snezana%26rft.date%3D2014-01-01%26rft.eissn%3D1177-8881%26rft.externalDBID%3Dn%252Fa%26rft.externalDocID%3D10_2147_DDDT_S66398%26rft.genre%3Darticle%26rft.issn%3D1177-8881%26rft.jtitle%3DDrug%2520design%252C%2520development%2520and%2520therapy%26rft.spage%3D859%26rft_id%3Dinfo%253Adoi%252F10.2147%252FDDDT.S66398%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,4-DOVE_PRESS_FREE-getFullTxt-object,5-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,6-MISCELLANEOUS_FREE_EJOURNALS-getFullTxt-object,7-GFMER_FREE_MEDICAL_JOURNALS-getFullTxt-object,8-PROQUEST_CENTRAL-getFullTxt-object,9-PUBMED_CENTRAL_OPEN_ACCESS_FREE-getFullTxt-object,10-COBIB_SI_LCL-getHolding-object,11-DOI-getDOI-object,12-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,13-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,14-REFWORKS_EXPORT_TOOL-getReference-object,15-SHERPA_RoMEO_LCL-getWebService-object,16-GOOGLE_SCHOLAR_FREE-getWebSearch-object,17-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.020231&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12884968-s2529760E-3B5B-11EF-9F4D-F83685CE164B" timestamp="2024-07-06T07:46:53Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000428820</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod</jnl:atitle>
<jnl:jtitle>Drug design development and Therapy</jnl:jtitle>
<jnl:date>2014-01-01</jnl:date>
<jnl:spage>859</jnl:spage>
<jnl:issn>1177-8881</jnl:issn>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1177-8881</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:ab944f3eaab79ddef8fa3396ca013487fa7afaa9</ctx:identifier>
<ctx:identifier>urn:UUID:s2529760E-3B5B-11EF-9F4D-F83685CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)